CN| EN

Home > News  > Company News

Annoroad has passed the second external quality assessment of national tumor somatic mutation high-throughput sequence and testing with a full score

2017-12-20

The Medical Laboratory of Annoroad Gene Tech has passed the second external quality assessment of national tumor somatic mutation high-throughput sequencing and testing with a full score.


Recently, the National Center of Clinical Laboratories (NCCL) has released the result of Second External Quality Assessment (also Referred to as Proficiency Testing) of National Tumor Somatic Mutation High-throughput Sequencing and Testing. This external quality assessment was participated by 102 laboratories from 18 provinces (cities and autonomous regions), and there were 91 laboratories reported the quality assessment results. The quality assessment has tested 6 samples and 3 mutation types (INDEL, SNV, CNV) with a qualification rate of 89.0% (81/91) and a full-score laboratory ratio of 85.7% (78/91). Among them, there were 19 laboratories in Beijing participated, and as one of them, the Medical Laboratory of Annoroad Gene Tech has passed this external quality assessment with a full score, which demonstrates Annoroad’s capacity and profession in tumor high-throughput gene testing again. In addition to the three mutation types INDEL, SNV, CNV required to be tested by this external quality assessment, Annoroad can also provide the fusion gene mutation testing accurately.

The Medical Laboratory of Annoroad Gene Tech. (Beijing) Co., Ltd., since its establishment, has been strictly controlling the operation regulation, process control, quality supervision and other links and engaging in providing stable and reliable testing services for the clinic and participating in the external quality assessment organized by the National Center of Clinical Laboratories actively every year, and in addition to the NGS technical platform, Annoroad’s digital PCR testing technical platform and others have also passed the assessment with excellent scores. Annoroad adheres to the concept of “gene technology, let the life shine”, benefits the public and returns the support and trust of each tester.


Copyright2012 Annoroad.com

All rights reserved Annoroad Gene Technology 京ICP备12029022号-1